Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von OldOrangeEyes 

Aytu BioScience Inc diskutieren

Aytu Biopharma Inc.

WKN: A3D38R / Symbol: AYTU / Name: Aytu Biopharma / Aktie / Micro Cap /

1,76 €
-1,12 %

Sell Aytu BioScience Inc

Aytu BioPharma, Inc. (NASDAQ: AYTU) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock.
Ratings data for AYTU provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 10,24
Veränderung
Endet am 30.06.26

Aytu BioPharma Inc. (NASDAQ: AYTU) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for AYTU provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 6,79
Veränderung
Endet am 01.07.26

Aytu BioPharma Inc. (NASDAQ: AYTU) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for AYTU provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 10,65
Veränderung
Endet am 25.09.26

Aytu BioPharma (NASDAQ:AYTU) had its price target raised by analysts at Ascendiant Capital Markets from $12.00 to $12.50. They now have a "buy" rating on the stock.
Ratings data for AYTU provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 5,96
Veränderung
Endet am 25.09.26

Aytu BioPharma (NASDAQ:AYTU) had its price target lowered by analysts at Maxim Group from $9.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for AYTU provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 11,16
Veränderung
Endet am 10.12.26

Aytu BioPharma (NASDAQ:AYTU) had its price target raised by analysts at Ascendiant Capital Markets from $12.50 to $13.00. They now have a "buy" rating on the stock.
Ratings data for AYTU provided by MarketBeat